Literature DB >> 10343188

EEG changes following scopolamine administration in healthy subjects. Quantitative analysis during rest and photic stimulation.

M Kikuchi1, Y Wada, Y Nanbu, A Nakajima, H Tachibana, T Takeda, T Hashimoto.   

Abstract

This study examined the effects of the anticholinergic drug, scopolamine (0.25 mg) in 16 right-handed healthy volunteers. EEGs were recorded before and 60 min after intramuscular administration, and spectral analysis was performed on EEGs recorded at rest and during photic stimulation. Each subject was also evaluated by the Wechsler Memory Scale (WMS; form 1 or 2) before and 90 min after drug administration. In the resting EEG, the scopolamine administration resulted in a significant increase in the absolute power on the delta band (2.0- 3.8 Hz) and in the relative power on the delta and theta-1 bands (4.0-5.8 Hz) mainly over the central and parieto-occipital regions. In contrast, scopolamine significantly decreased the relative alpha-2 band (9.2-12.8 Hz) power mainly over the frontal regions and the absolute alpha-2 band power at most of the recording sites. The analysis of stimulus data showed that scopolamine significantly decreased fundamental photic driving responses elicited by photic stimulation at 15 Hz, with significant effects confined to the occipital regions. These EEG changes occurred in association with a significant reduction in total WMS scores as well as in scores of logical and visual memory subtests. These findings suggest that, in addition to cognitive impairments, central cholinergic dysfunction can cause EEG changes under both nonstimulus and stimulus conditions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10343188     DOI: 10.1159/000026588

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  10 in total

1.  Brain Network Activation (BNA) reveals scopolamine-induced impairment of visual working memory.

Authors:  Amit Reches; Naama Levy-Cooperman; Ilan Laufer; Revital Shani-Hershkovitch; Keren Ziv; Dani Kerem; Noga Gal; Yaki Stern; Guy Cukierman; Myroslava K Romach; Edward M Sellers; Amir B Geva
Journal:  J Mol Neurosci       Date:  2014-02-18       Impact factor: 3.444

2.  Model-based exposure-response analysis to quantify age related differences in the response to scopolamine in healthy subjects.

Authors:  Ricardo Alvarez-Jimenez; Geert Jan Groeneveld; Joop M A van Gerven; Sebastiaan C Goulooze; Anne Catrien Baakman; Justin L Hay; Jasper Stevens
Journal:  Br J Clin Pharmacol       Date:  2016-07-14       Impact factor: 4.335

3.  Modulation of memory and visuospatial processes by biperiden and rivastigmine in elderly healthy subjects.

Authors:  E Wezenberg; R J Verkes; B G C Sabbe; G S F Ruigt; W Hulstijn
Journal:  Psychopharmacology (Berl)       Date:  2005-10-12       Impact factor: 4.530

4.  Propofol anesthesia and sleep: a high-density EEG study.

Authors:  Michael Murphy; Marie-Aurélie Bruno; Brady A Riedner; Pierre Boveroux; Quentin Noirhomme; Eric C Landsness; Jean-Francois Brichant; Christophe Phillips; Marcello Massimini; Steven Laureys; Giulio Tononi; Mélanie Boly
Journal:  Sleep       Date:  2011-03-01       Impact factor: 5.849

5.  Quantitative EEG abnormalities are associated with memory impairment in recently abstinent methamphetamine-dependent individuals.

Authors:  Ari D Kalechstein; Richard De la Garza; Thomas F Newton; Michael F Green; Ian A Cook; Andrew F Leuchter
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2009       Impact factor: 2.198

6.  Sleep and EEG Power Spectral Analysis in Three Transgenic Mouse Models of Alzheimer's Disease: APP/PS1, 3xTgAD, and Tg2576.

Authors:  Brianne A Kent; Stephen M Strittmatter; Haakon B Nygaard
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 7.  On the Physiological Modulation and Potential Mechanisms Underlying Parieto-Occipital Alpha Oscillations.

Authors:  Diego Lozano-Soldevilla
Journal:  Front Comput Neurosci       Date:  2018-04-04       Impact factor: 2.380

8.  TAK-071, a muscarinic M1 receptor positive allosteric modulator, attenuates scopolamine-induced quantitative electroencephalogram power spectral changes in cynomolgus monkeys.

Authors:  Emi Kurimoto; Masato Nakashima; Haruhide Kimura; Motohisa Suzuki
Journal:  PLoS One       Date:  2019-03-11       Impact factor: 3.240

9.  EEG machine learning for accurate detection of cholinergic intervention and Alzheimer's disease.

Authors:  Sonja Simpraga; Ricardo Alvarez-Jimenez; Huibert D Mansvelder; Joop M A van Gerven; Geert Jan Groeneveld; Simon-Shlomo Poil; Klaus Linkenkaer-Hansen
Journal:  Sci Rep       Date:  2017-07-18       Impact factor: 4.379

Review 10.  Sleep and its regulation: An emerging pathogenic and treatment frontier in Alzheimer's disease.

Authors:  Brianne A Kent; Howard H Feldman; Haakon B Nygaard
Journal:  Prog Neurobiol       Date:  2020-08-30       Impact factor: 11.685

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.